The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function
Open accessAbstract
Expansion of antigen-experienced CD8+ T cells is critical for the success of tumour-infiltrating lymphocyte (TIL)-adoptive cell therapy (ACT) in patients with cancer 1. Interleukin-2 (IL-2) acts as a key regulator of CD8+ cytotoxic T lymphocyte functions by promoting expansion and cytotoxic capability 2,3. Therefore, it is essential to comprehend mechanistic barriers to IL-2 sensing in the tumour microenvironment to implement strategies to reinvigorate IL-2 responsiveness and T cell antitumour responses. Here we report that prostaglandin E2 (PGE 2), a known negative regulator of immune response in the tumour microenvironment 4,5, is present at high concentrations in tumour tissue from patients and leads to impaired IL-2 sensing in human CD8+ TILs via the PGE 2 receptors EP2 and EP4. Mechanistically, PGE 2 inhibits IL-2 sensing in TILs by downregulating the IL-2Rγ c chain, resulting in defective assembly of IL-2Rβ–IL2Rγ c membrane dimers. This results in impaired IL-2–mTOR adaptation and PGC1α transcriptional repression, causing oxidative stress and ferroptotic cell death in tumour-reactive TILs. Inhibition of PGE 2 signalling to EP2 and EP4 during TIL expansion for ACT resulted in increased IL-2 sensing, leading to enhanced proliferation of tumour-reactive TILs and enhanced tumour control once the cells were transferred in vivo. Our study reveals fundamental features that underlie impairment of human TILs mediated by PGE 2 in the tumour microenvironment. These findings have therapeutic implications for cancer immunotherapy and cell therapy, and enable the development of targeted strategies to enhance IL-2 sensing and amplify the IL-2 response in TILs, thereby promoting the expansion of effector T cells with enhanced therapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nguyen, T. B., Louie, S. M., Daniele, J. R., Tran, Q., Dillin, A., Zoncu, R., Nomura, D. K., & Olzmann, J. A. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.06.003 · Cited by 610
Qiu, B., Ackerman, D., Sanchez, D. J., Li, B., Ochocki, J. D., Grazioli, A., Bobrovnikova-Marjon, E., Diehl, J. A., Keith, B., & Simon, M. C. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1507 · Cited by 394
Cited by
The hallmarks of cancer immune evasion
Galassi, C., Chan, T. A., Vitale, I., & Galluzzi, L. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.09.010 · Cited by 565
Ferroptosis: principles and significance in health and disease
Chen, F., Kang, R., Tang, D., & Liu, J. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01564-3 · Cited by 285
Metadata
- Authors
- Morotti, M., Grimm, A. J., Hope, H. C., Arnaud, M., Desbuisson, M., Rayroux, N., Barras, D., Masid, M., Murgues, B., Chap, B. S., Ongaro, M., Rota, I. A., Ronet, C., Minasyan, A., Chiffelle, J., Lacher, S. B., Bobisse, S., Murgues, C., Ghisoni, E., Ouchen, K., Bou Mjahed, R., Benedetti, F., Abdellaoui, N., Turrini, R., Gannon, P. O., Zaman, K., Mathevet, P., Lelievre, L., Crespo, I., Conrad, M., Verdeil, G., Kandalaft, L. E., Dagher, J., Corria-Osorio, J., Doucey, M.-A., Ho, P.-C., Harari, A., Vannini, N., Böttcher, J. P., Dangaj Laniti, D., & Coukos, G.
- Venue
- Nature
- Published
- 2024-04-24
- Volume
- 629
- Issue
- 8011
- Pages
- 426-434
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W4395071408
- Cited by
- 221
- References
- 2
- FWCI
- 30.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function. https://app.cochat.ai/papers/10.1038/s41586-024-07352-w
- The paper
- Morotti, M., Grimm, A. J., Hope, H. C., Arnaud, M., Desbuisson, M., Rayroux, N., Barras, D., Masid, M., Murgues, B., Chap, B. S., Ongaro, M., Rota, I. A., Ronet, C., Minasyan, A., Chiffelle, J., Lacher, S. B., Bobisse, S., Murgues, C., Ghisoni, E., . . . Coukos, G. (2024). PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function. Nature. https://doi.org/10.1038/s41586-024-07352-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.